from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
Why Philip Morris (PM) Stock is a Compelling Investment Case
-
Key Things To Understand About New Relic’s (NYSE:NEWR) CEO Pay Cheque
-
Teladoc and Livongo merge in $18.5B deal
-
Moderna Q2 revenue rises amid COVID-19 vaccine development